|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-15
|
|
pubmed:abstractText |
To evaluate in patients with moderate to severe COPD whether a single morning dose of 24 microg formoterol from the Novolizer is not inferior to two divided doses of 12 microg formoterol inhaled in the morning and in the evening.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1094-5539
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4-13
|
|
pubmed:meshHeading |
pubmed-meshheading:17101285-Adult,
pubmed-meshheading:17101285-Aged,
pubmed-meshheading:17101285-Albuterol,
pubmed-meshheading:17101285-Bronchodilator Agents,
pubmed-meshheading:17101285-Double-Blind Method,
pubmed-meshheading:17101285-Drug Administration Schedule,
pubmed-meshheading:17101285-Ethanolamines,
pubmed-meshheading:17101285-Female,
pubmed-meshheading:17101285-Humans,
pubmed-meshheading:17101285-Male,
pubmed-meshheading:17101285-Middle Aged,
pubmed-meshheading:17101285-Nebulizers and Vaporizers,
pubmed-meshheading:17101285-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:17101285-Quality of Life,
pubmed-meshheading:17101285-Respiratory Function Tests
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial.
|
|
pubmed:affiliation |
Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany. welte.tobias@mh-hannover.de <welte.tobias@mh-hannover.de>
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
